Lucira Health Inc. (LHDX:NASDAQ) rocketted at $0.6, representing a gain of 440.1%. On Tue, Jan 03, 2023, LHDX:NASDAQ touched a New 2-Week High of $0.6. The stock appeared on our News Catalysts scanner on Tue, Jan 03, 2023 at 07:28 AM in the 'MISCELLANEOUS' category. From Tue, Dec 20, 2022, the stock recorded 12.50% Up Days and 22.22% Green Days
The stock spiked on Tue, Jan 03, 2023 at $0.87 with a volume of 195M+.
About Lucira Health Inc. (LHDX:NASDAQ)
Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits.
Top 10 Gainers:
- Jasper Therapeutics Inc. (JSPR:NASDAQ), 476.36%
- Lucira Health Inc. (LHDX:NASDAQ), 440.05%
- Horizon Global Corporation (HZN:NYSE), 342.39%
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 84.08%
- Gelesis Holdings Inc. (GLS:NYSE), 79.06%
- Motorsport Games Inc. (MSGM:NASDAQ), 67.47%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 56.34%
- Viveve Medical, Inc. (VIVE:NASDAQ), 54.76%
- Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 49.39%
- iBio, Inc. (IBIO:NYSEMKT), 48.51%